Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2022

10.05.2021 | Original Article

Increased Risk of Advanced Colonic Adenomas and Timing of Surveillance Colonoscopy Following Solid Organ Transplantation

verfasst von: Motaz H. Ashkar, Jacqueline Chen, Corey Shy, Jeffrey S. Crippin, Chien-Huan Chen, Gregory S. Sayuk, Nicholas O. Davidson

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Detection and removal of colonic adenomatous polyps (CAP) decreases colorectal cancer (CRC) development, particularly with more or larger polyps or polyps with advanced villous/dysplastic histology. Immunosuppression following solid organ transplantation (SOT) may accelerate CAP development and progression compared to average-risk population but the benefit of earlier colonoscopic surveillance is unclear.

Aims

Study the impact of maintenance immunosuppression post-SOT on developmental timing, multiplicity and pathological features of CAP, by measuring incidence of advanced CAP (villous histology, size ≥ 10 mm, ≥ 3 polyps, presence of dysplasia) post-SOT and the incidence of newly diagnosed CRC compared to average-risk age-matched population.

Methods

Single-center retrospective cohort study of SOT recipients.

Results

295 SOT recipients were included and were compared with 291 age-matched average-risk controls. The mean interval between screening and surveillance colonoscopies between SOT and control groups was 6.3 years vs 5.9 years (p = 0.13). Post-SOT maintenance immunosuppression mean duration averaged 59.9 months at surveillance colonoscopy. On surveillance examinations, SOT recipients exhibited more advanced (≥ 10 mm) adenomas compared to matched controls (9.2% vs. 3.8%, p = 0.034; adjusted OR 2.38; 95% CI 1.07–5.30).

Conclusion

SOT recipients appear at higher risk for developing advanced CAP, suggesting that earlier surveillance should be considered.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7–34.PubMed Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7–34.PubMed
2.
Zurück zum Zitat Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658–662.PubMedCrossRef Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658–662.PubMedCrossRef
3.
Zurück zum Zitat Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739–750.PubMedCrossRef Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739–750.PubMedCrossRef
4.
Zurück zum Zitat Koudougou C, Bonneville M, Matysiak-Budnik T, Touchefeu Y. Review article: antitumoural immunity in colorectal cancer - current and potential future implications in clinical practice. Aliment Pharmacol Ther 2013;38:3–15.PubMedCrossRef Koudougou C, Bonneville M, Matysiak-Budnik T, Touchefeu Y. Review article: antitumoural immunity in colorectal cancer - current and potential future implications in clinical practice. Aliment Pharmacol Ther 2013;38:3–15.PubMedCrossRef
5.
Zurück zum Zitat Trivedi MH, Agrawal S, Muscato MS, Metzler MH, Marshall JB. High grade, synchronous colon cancers after renal transplantation: were immunosuppressive drugs to blame? Am J Gastroenterol 1999;94:3359–3361.PubMedCrossRef Trivedi MH, Agrawal S, Muscato MS, Metzler MH, Marshall JB. High grade, synchronous colon cancers after renal transplantation: were immunosuppressive drugs to blame? Am J Gastroenterol 1999;94:3359–3361.PubMedCrossRef
6.
Zurück zum Zitat Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991;23:1101–1103.PubMed Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991;23:1101–1103.PubMed
7.
Zurück zum Zitat Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004;21:137–148.PubMedCrossRef Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004;21:137–148.PubMedCrossRef
8.
Zurück zum Zitat Senatore FJ, Murali S, Dasanu CA. Accelerated premalignant polyposis and second colon cancers: incriminating immunosuppression, radiotherapy, and systemic chemotherapy agents. J Gastrointest Cancer 2016;47:152–156.PubMedCrossRef Senatore FJ, Murali S, Dasanu CA. Accelerated premalignant polyposis and second colon cancers: incriminating immunosuppression, radiotherapy, and systemic chemotherapy agents. J Gastrointest Cancer 2016;47:152–156.PubMedCrossRef
9.
Zurück zum Zitat Parikshak M, Pawlak SE, Eggenberger JC, Lee CS, Szilagy EJ, Margolin DA. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum 2002;45:1655–1660.PubMedCrossRef Parikshak M, Pawlak SE, Eggenberger JC, Lee CS, Szilagy EJ, Margolin DA. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum 2002;45:1655–1660.PubMedCrossRef
10.
Zurück zum Zitat Fabia R, Levy MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998;176:265–269.PubMedCrossRef Fabia R, Levy MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998;176:265–269.PubMedCrossRef
11.
Zurück zum Zitat Rudraraju M, Osowo AT, Singh V, Carey EJ. Do patients need more frequent colonoscopic surveillance after liver transplantation? Transplant Proc 2008;40:1522–1524.PubMedCrossRef Rudraraju M, Osowo AT, Singh V, Carey EJ. Do patients need more frequent colonoscopic surveillance after liver transplantation? Transplant Proc 2008;40:1522–1524.PubMedCrossRef
12.
Zurück zum Zitat Meyer KC, Francois ML, Thomas HK, Radford KL, Hawes DS, Mack TL et al. Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros 2011;10:366–369.PubMedCrossRef Meyer KC, Francois ML, Thomas HK, Radford KL, Hawes DS, Mack TL et al. Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros 2011;10:366–369.PubMedCrossRef
13.
Zurück zum Zitat Lee HS, Yoo DJ, Park HW, Yang DH, Myung SJ, Yang SK et al. Is a stricter colonoscopy screening protocol necessary in liver transplant recipients? Comparison with an average-risk population. Dis Colon Rectum 2014;57:976–982.PubMedCrossRef Lee HS, Yoo DJ, Park HW, Yang DH, Myung SJ, Yang SK et al. Is a stricter colonoscopy screening protocol necessary in liver transplant recipients? Comparison with an average-risk population. Dis Colon Rectum 2014;57:976–982.PubMedCrossRef
14.
Zurück zum Zitat Atassi T, Thuluvath PJ. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy. J Clin Gastroenterol 2003;37:72–73.PubMedCrossRef Atassi T, Thuluvath PJ. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy. J Clin Gastroenterol 2003;37:72–73.PubMedCrossRef
15.
Zurück zum Zitat Aigner F, Boeckle E, Albright J, Kilo J, Boesmueller C, Conrad F et al. Malignancies of the colorectum and anus in solid organ recipients. Transpl Int 2007;20:497–504.PubMedCrossRef Aigner F, Boeckle E, Albright J, Kilo J, Boesmueller C, Conrad F et al. Malignancies of the colorectum and anus in solid organ recipients. Transpl Int 2007;20:497–504.PubMedCrossRef
16.
Zurück zum Zitat Albright JB, Bonatti H, Stauffer J, Dickson RC, Nguyen J, Harnois D et al. Colorectal and anal neoplasms following liver transplantation. Colorectal Dis 2010;12:657–666.PubMedCrossRef Albright JB, Bonatti H, Stauffer J, Dickson RC, Nguyen J, Harnois D et al. Colorectal and anal neoplasms following liver transplantation. Colorectal Dis 2010;12:657–666.PubMedCrossRef
18.
Zurück zum Zitat Johnson EE, Leverson GE, Pirsch JD, Heise CP. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg 2007;11:272–279.PubMedCrossRef Johnson EE, Leverson GE, Pirsch JD, Heise CP. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg 2007;11:272–279.PubMedCrossRef
19.
Zurück zum Zitat Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998;66:1193–1200.PubMedCrossRef Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998;66:1193–1200.PubMedCrossRef
20.
Zurück zum Zitat Park HY, Chang BJ, Lim SW, Kim J, Kim JY, Chang DK et al. Risk of colorectal neoplasia in patients with solid organ transplantation. Clin Transplant 2012;26:50–56.PubMedCrossRef Park HY, Chang BJ, Lim SW, Kim J, Kim JY, Chang DK et al. Risk of colorectal neoplasia in patients with solid organ transplantation. Clin Transplant 2012;26:50–56.PubMedCrossRef
21.
Zurück zum Zitat Spier BJ, Walker AJ, Cornett DD, Pfau PR, Halberg RB, Said A. Screening colonoscopy and detection of neoplasia in asymptomatic, average-risk, solid organ transplant recipients: case-control study. Transpl Int 2010;23:1233–1238.PubMedCrossRef Spier BJ, Walker AJ, Cornett DD, Pfau PR, Halberg RB, Said A. Screening colonoscopy and detection of neoplasia in asymptomatic, average-risk, solid organ transplant recipients: case-control study. Transpl Int 2010;23:1233–1238.PubMedCrossRef
22.
Zurück zum Zitat Weismuller TJ, Bleich F, Negm AA, Schneider A, Lankisch TO, Manns MP et al. Screening colonoscopy in liver transplant candidates: risks and findings. Clin Transplant 2013;27:E161–E168.PubMedCrossRef Weismuller TJ, Bleich F, Negm AA, Schneider A, Lankisch TO, Manns MP et al. Screening colonoscopy in liver transplant candidates: risks and findings. Clin Transplant 2013;27:E161–E168.PubMedCrossRef
23.
Zurück zum Zitat Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104–117.PubMedCrossRef Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104–117.PubMedCrossRef
24.
Zurück zum Zitat Singh KE, Taylor TH, Pan CG, Stamos MJ, Zell JA. Colorectal cancer incidence among young adults in California. J Adolesc Young Adult Oncol 2014;3:176–184.PubMedPubMedCentralCrossRef Singh KE, Taylor TH, Pan CG, Stamos MJ, Zell JA. Colorectal cancer incidence among young adults in California. J Adolesc Young Adult Oncol 2014;3:176–184.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Burt RW, DiSario JA, Cannon-Albright L. Genetics of colon cancer: impact of inheritance on colon cancer risk. Annu Rev Med 1995;46:371–379.PubMedCrossRef Burt RW, DiSario JA, Cannon-Albright L. Genetics of colon cancer: impact of inheritance on colon cancer risk. Annu Rev Med 1995;46:371–379.PubMedCrossRef
26.
Zurück zum Zitat Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 2017;35:1086–1095.PubMedPubMedCentralCrossRef Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 2017;35:1086–1095.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Mork ME, You YN, Ying J, Bannon SA, Lynch PM, Rodriguez-Bigas MA et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J Clin Oncol 2015;33:3544–3549.PubMedPubMedCentralCrossRef Mork ME, You YN, Ying J, Bannon SA, Lynch PM, Rodriguez-Bigas MA et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J Clin Oncol 2015;33:3544–3549.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Ahnen DJ, Wade SW, Jones WF, Sifri R, Mendoza Silveiras J, Greenamyer J et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 2014;89:216–224.PubMedCrossRef Ahnen DJ, Wade SW, Jones WF, Sifri R, Mendoza Silveiras J, Greenamyer J et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 2014;89:216–224.PubMedCrossRef
29.
Zurück zum Zitat Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol 2017;3:464–471.PubMedPubMedCentralCrossRef Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol 2017;3:464–471.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9:S1-155. Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9:S1-155.
31.
Zurück zum Zitat Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000;11:S1-86.PubMedCrossRef Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000;11:S1-86.PubMedCrossRef
32.
Zurück zum Zitat Baker R, Jardine A, Andrews P. Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient. Nephron Clin Pract 2011;118:c311–c347.PubMedCrossRef Baker R, Jardine A, Andrews P. Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient. Nephron Clin Pract 2011;118:c311–c347.PubMedCrossRef
33.
Zurück zum Zitat Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M et al. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:798–825.PubMedCrossRef Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M et al. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:798–825.PubMedCrossRef
34.
Zurück zum Zitat Transplantation EEGoR-European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. Nephrol Dial Transplant 2002;17:4–6. Transplantation EEGoR-European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. Nephrol Dial Transplant 2002;17:4–6.
35.
Zurück zum Zitat Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:3–26.PubMedCrossRef Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:3–26.PubMedCrossRef
36.
Zurück zum Zitat Kim JB, Han DS, Lee HL, Kim JP, Jeon YC, Sohn JH et al. The recurrence rate of colon polyp after polypectomy and the interval of surveillance colonoscopy: predictors of early development of advanced polyp. Korean J Gastroenterol 2004;44:77–83.PubMed Kim JB, Han DS, Lee HL, Kim JP, Jeon YC, Sohn JH et al. The recurrence rate of colon polyp after polypectomy and the interval of surveillance colonoscopy: predictors of early development of advanced polyp. Korean J Gastroenterol 2004;44:77–83.PubMed
37.
Zurück zum Zitat Safaeian M, Robbins HA, Berndt SI, Lynch CF, Fraumeni JF Jr, Engels EA. Risk of colorectal cancer after solid organ transplantation in the United States. Am J Transplant 2016;16:960–967.PubMedPubMedCentralCrossRef Safaeian M, Robbins HA, Berndt SI, Lynch CF, Fraumeni JF Jr, Engels EA. Risk of colorectal cancer after solid organ transplantation in the United States. Am J Transplant 2016;16:960–967.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010;10:1889–1896.PubMedCrossRef Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010;10:1889–1896.PubMedCrossRef
39.
Zurück zum Zitat Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891–1901.PubMedPubMedCentralCrossRef Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891–1901.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Acuna SA, Huang JW, Scott AL, Micic S, Daly C, Brezden-Masley C et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant 2017;17:103–114.PubMedCrossRef Acuna SA, Huang JW, Scott AL, Micic S, Daly C, Brezden-Masley C et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant 2017;17:103–114.PubMedCrossRef
41.
Zurück zum Zitat Papaconstantinou HT, Sklow B, Hanaway MJ, Gross TG, Beebe TM, Trofe J et al. Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum 2004;47:1898–1903.PubMedCrossRef Papaconstantinou HT, Sklow B, Hanaway MJ, Gross TG, Beebe TM, Trofe J et al. Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum 2004;47:1898–1903.PubMedCrossRef
42.
Zurück zum Zitat Prenner S, Levitsky J. Comprehensive review on colorectal cancer and transplant. Am J Transplant 2017;17:2761–2774.PubMedCrossRef Prenner S, Levitsky J. Comprehensive review on colorectal cancer and transplant. Am J Transplant 2017;17:2761–2774.PubMedCrossRef
43.
Zurück zum Zitat Yokoyama I, Hayashi S, Kobayashi T, Negita M, Yasutomi M, Uchida K et al. Immunosuppressive drugs and their effect on experimental tumor growth. Transpl Int 1995;8:251–255.PubMedCrossRef Yokoyama I, Hayashi S, Kobayashi T, Negita M, Yasutomi M, Uchida K et al. Immunosuppressive drugs and their effect on experimental tumor growth. Transpl Int 1995;8:251–255.PubMedCrossRef
44.
Zurück zum Zitat Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999;397:530–534.PubMedCrossRef Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999;397:530–534.PubMedCrossRef
45.
Zurück zum Zitat Penn I. Why do immunosuppressed patients develop cancer? Crit Rev Oncog 1989;1:27–52.PubMed Penn I. Why do immunosuppressed patients develop cancer? Crit Rev Oncog 1989;1:27–52.PubMed
46.
Zurück zum Zitat Oey RC, van Tilburg L, Erler NS, Metselaar HJ, Spaander MCW, van Buuren HR et al. The yield and safety of screening colonoscopy in patients evaluated for liver transplantation. Hepatology 2019;69:2598–2607.PubMed Oey RC, van Tilburg L, Erler NS, Metselaar HJ, Spaander MCW, van Buuren HR et al. The yield and safety of screening colonoscopy in patients evaluated for liver transplantation. Hepatology 2019;69:2598–2607.PubMed
Metadaten
Titel
Increased Risk of Advanced Colonic Adenomas and Timing of Surveillance Colonoscopy Following Solid Organ Transplantation
verfasst von
Motaz H. Ashkar
Jacqueline Chen
Corey Shy
Jeffrey S. Crippin
Chien-Huan Chen
Gregory S. Sayuk
Nicholas O. Davidson
Publikationsdatum
10.05.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06987-3

Weitere Artikel der Ausgabe 5/2022

Digestive Diseases and Sciences 5/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.